Services-Commercial Physical & Biological Research
Headquarters
Wilmington, DE 19803
Fiscal year end
2025 (FY)
Market Data
Close
$108.59
Change
-$2.75
Change %
-2.47%
Volume
130,840
INCY · trading date Oct 13, 2026 · previous close $111.34 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$5.14B
Net income
$1.29B
Total assets
$6.96B
Total liabilities
$1.79B
Stockholders' equity
$5.17B
Cash & equivalents
$3.10B
Operating income
$1.51B
Operating cash flow
$1.41B
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-02-10.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
29.5%
Net margin
25.0%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
25.7%
Equity / assets
74.3%
CapEx / revenue
—
Operating cash flow / net income
1.10×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Wilmington, DE 19803
1801 AUGUSTINE CUT-OFF
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:23 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.